Translating Ideas into Commercial Biomaterial Devices: A Path to Improving Healthcare.

biomaterial devices commercialization pathways healthcare innovation industry-academia partnerships translation process

Journal

ACS biomaterials science & engineering
ISSN: 2373-9878
Titre abrégé: ACS Biomater Sci Eng
Pays: United States
ID NLM: 101654670

Informations de publication

Date de publication:
07 Mar 2024
Historique:
medline: 7 3 2024
pubmed: 7 3 2024
entrez: 7 3 2024
Statut: aheadofprint

Résumé

The medical device industry is undergoing substantial transformations, looking to face the increasing pressures on healthcare systems and fundamental shifts in healthcare delivery. There is an ever-growing emphasis on identifying underserved clinical requirements and enhancing industry-academia partnerships to accelerate innovative solutions. In this context, an analysis of the requirements for translation, highlighting support and funding for innovation to transform an idea for a biomaterial device into a commercially available product, is discussed.

Identifiants

pubmed: 38452343
doi: 10.1021/acsbiomaterials.3c01441
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Auteurs

María Emilia Brassesco (ME)

Laboratório Associado, Escola Superior de Biotecnologia, Centro de Biotecnologia e Química Fina (CBQF), Universidade Católica Portuguesa, Rua Diogo Botelho 1327, Porto 4169-005, Portugal.

João Cortez (J)

Laboratório Associado, Escola Superior de Biotecnologia, Centro de Biotecnologia e Química Fina (CBQF), Universidade Católica Portuguesa, Rua Diogo Botelho 1327, Porto 4169-005, Portugal.

Valentina Triacca (V)

Lymphatica Medtech SA, EPFL Innovation Park Bâtiment, Lausanne E 1015, Switzerland.

Julien Payen (J)

Lattice Medical, 80 Rue du Dr Yersin, Loos 59120, France.

Yves Bayon (Y)

Medtronic - Sofradim Production, 116 avenue du Formans, Trevoux 01600, France.

Classifications MeSH